AEON Biopharma Inc
AEON.WS
AEON.WS was delisted on the 26th of April, 2024.
0 hedge funds and large institutions have $0 invested in AEON Biopharma Inc in 2024 Q2 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 30 closing their positions.
100% less funds holding
Funds holding: 30 → 0 (-30)
100% less capital invested
Capital invested by funds: $3.62M → $0 (-$3.62M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 30
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DKCM
Davidson Kempner Capital Management
New York
|
-$532K |
| 2 |
LP
LMR Partners
London,
United Kingdom
|
-$362K |
| 3 |
AC
Athos Capital
Hong Kong
|
-$295K |
| 4 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$274K |
| 5 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
-$250K |
AEON.WS Hedge Fund Activity: Q2 2024 in Review
0 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in AEON Biopharma Inc (AEON.WS) for Q2 2024, worth a combined $0 — down 100% from $3.62M a quarter earlier.
Sellers outnumbered buyers: 30 funds closed out of AEON.WS and 0 opened new positions — a net loss of 30 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Davidson Kempner Capital Management, exiting entirely with an estimated $532K sold.
- 0 institutional investors held AEON Biopharma Inc (AEON.WS) as of Q2 2024, down from 30 in Q1 2024.
- Funds reported $0 of AEON Biopharma Inc stock for Q2 2024, down 100% quarter-over-quarter.
- 0 funds opened new AEON Biopharma Inc positions in Q2 2024 and 30 closed out, a net change of -30 holders.
- The largest AEON Biopharma Inc seller in Q2 2024 was Davidson Kempner Capital Management, an estimated $532K sold.
Based on aggregated 13F filings for Q2 2024.